ACST: Acasti Pharma Company Current Liabilities

Acasti Pharma Inc. (ACST) - corporate logo

Acasti Pharma (ACST) operations are independent of economic fluctuations, as demand for cardiology care remains stable. The business relies on royalty payments, utilizing outsourced production to minimize capital expenditures. The company is currently in the testing phase for new molecules, with resources allocated to clinical trials. This metric stands at 0.00. The chart of short-term liability costs is presented below.

ACST (Acasti) Company Short-Term Debts history from 07/04/2022 to 10/28/2024

Summary analytical data breakdowns for Acasti Pharma Inc (ACST)

- current quotes and average value forecast:
Price Chart Acasti|ACST - Fair Value Consensus
- market capitalization information:
Market Valuation Acasti Pharma Inc.|ACST - Aggregate Business Value
- balance sheet net asset value indicators:
Book Value per Share Acasti Pharma|ACST - Book Capitalization|Market Capitalization to Book Value Ratio acastipharma.com|ACST - Cumulative Company Assets
- business debt structure and liquidity details:
Total Debt to Capital Acasti Pharma|ACST - Long-Term Debt to Capital|Short-Term Debt to Equity Acasti|ACST - Company Total Debt Obligations|Debt to Book Value Acasti Pharma Inc.|ACST - Amount of Long-Term Liabilities|Company Short-Term Debts Acasti Pharma|Quick Liquidity Indicator acastipharma.com
- net income and valuation multiples indicators:
ACST - Final Profit
Fundamental company analysis:acastipharma.com - ACST
Manufactured products of Acasti

By utilizing contract manufacturing organizations (CMO) in the US, Acasti Pharma (ACST) minimizes capital expenditures, which directly impacts its liability structure. By analyzing the evolution of short-term debt load relative to working capital, an investor can assess the balance between reducing default risk and a potential slowdown in expansion due to limited credit lines.

Who Acasti Pharma competes with

REGN - Company Short-Term Debt|Company Short-Term Loans and Borrowings IRTC (iRhythm Technologies, Inc.)|LNTH (Lantheus Medical Imaging) - Company Current Liabilities|MLYS: Amount of Current Liabilities|HTFL (HeartFlow Inc) - Company Short-Term Debts|Company Short-Term Debts kestramedical.com|Company Short-Term Debts ESPR|Company Current Liabilities Amarin Corporation AMRN|Company Short-Term Debts AVR (Anteris Technologies)|Company Short-Term Debts Tenaya TNYA|CVRX - Company Short-Term Debt|Short-Term Debt Volume milestonepharma.com MIST|CRDL (cardiolrx.com) - Company Current Liabilities|BEAT: Amount of Current Liabilities|TENX (Tenax Therapeutics, Inc) - Company Short-Term Debts|Adagio Medical, Inc. (ADGM) - Short-Term Debt Volume|Company Current Liabilities BCDA (BioCardia, Inc.)|VTAK (catheterprecision.com) - Company Short-Term Loans and Borrowings|Company Short-Term Debt ARCA Biopharma, Inc. ABIO|AVTE (Aerovate Therapeutics Inc.) - Current Liabilities|Verve - Company Short-Term Debts|Company Short-Term Loans and Borrowings WINT (Windtree Therapeutics)